2025 Sponsors & Exhibitors

As a partner of choice for the pharmaceutical and biotech companies across the globe, BD Medical - Pharmaceutical Systems provides a broad range of parenteral drug delivery systems including glass and plastic prefillable syringes, safety and shielding systems as well as advanced drug delivery solutions that help ensure smooth delivery considering drug complexity, viscosity and dosing volume. With an emphasis on patient centered innovations and strong technical expertise, BD Medical - Pharmaceutical Systems partners with pharmaceutical and biotechnology companies to help them achieve their goals. We support product launch and life cycle management through a comprehensive set of services and solutions from development to launch that help to de-risk the combination product development process.

EdgeOne Medical is a device development professional service organization serving the bio-pharmaceutical industry with end-to-end offerings to navigate the development and commercialization pathway of combination products.  Backed by seasoned industry experts and a deeply collaborative, client-first mindset, EdgeOne Medical has a track record of supporting over 135 clients across a full range of device modalities including pre-filled syringes, auto- & pen injectors, inhalers, on body injectors, vial access devices, custom device delivery systems, complex systems, digital apps, connected devices and innovative medical device technologies. EdgeOne Medical stands as the only true Integrated Device Partner for Combination Products, with a cross-functional device team complemented by in-house, FDA inspected device testing labs operated by experienced device engineers to help clients deliver safe, effective, and patient-centric solutions.  Founded in 2012, EdgeOne Medical is headquartered in Wheeling, IL.

Phillips-Medisize, a CDMO of drug delivery, diagnostic and medtech devices, provides innovative products and strategy, design, development and manufacturing services to the global industries. We offer complete end-to-end capabilities from early device strategy through design and development, human factors engineering, clinical production to full scale production, including drug handling and finishing. We have a particular focus on drug delivery devices and connected health, and played an integral role in the first FDA approval for a fully connected drug delivery device, with a regulated companion digital service. Based on our track record of device development and manufacture, and responding to market requirements, we have increased our focus on developing platform-based drug delivery devices. These target the markets need for flexible, cost effective, timely solutions that meet both the industries needs and those of the patient. Our platforms include a smart autoinjector, wearable bolus and a large volume injector and a Mini-tablet Dispenser. For more information, visit www.phillipsmedisize.com.

SHL Medical is a pioneering leader in self-injection solutions, such as autoinjectors. Driven by our purpose of “enabling patients’ independence”, we partner with leading pharma and biotech companies to develop self-injection systems and digital solutions that enhance patients’ treatment experience and quality of life. Our customers benefit from our proven track record and scalable, global manufacturing excellence, with locations across three continents and headquarters in Switzerland. By focusing on innovation, we challenge the status quo and shape the future of state-of-the-art drug delivery. We cover the entire drug delivery value chain, providing peace of mind through our end-to-end services, from design, development, to final assembly, labeling, and packaging.

Crux was founded to address challenging technical briefs and deliver compelling solutions for the drug delivery and medical device sectors. Based in Bristol, United Kingdom and Boston, Massachusetts , our technical team champion evidence-based problem solving, coupling world-class equipment, software and facilities with a scientific approach to maximise success. Be it discovering unmet user needs, developing novel products or deploying new technologies, our team are dedicated to solving our client’s biggest problems. To learn more, visit www.cruxproductdesign.com

Gannet BioChem is a specialty Contract Development and Manufacturing Organization (CDMO) in Huntsville, Alabama USA with more than 30 years of experience in the development, scale up, and GMP manufacturing of polyethylene glycol (PEG) reagents, activated polymers, and bioconjugation. These reagents are critical components in many advanced biopharmaceutical drugs. Founded in 1992 as Shearwater Polymers, the company later became part of Nektar Therapeutics before re-establishing as Gannet BioChem under Ampersand Capital Partners in 2024. Our FDA-inspected 124,000 square foot facility supports both small scale and commercial production. We provide end to end GMP services including raw material sourcing, process development, analytical testing, packaging, and manufacturing. Our products have been used in nine FDA approved therapeutics and continue to support several currently marketed drugs with global sales of more than three billion dollars. With an average employee tenure of 13 years, our team brings unmatched technical expertise and long term knowledge to every project. Located near one of the largest life sciences research parks in the United States, we are well positioned to collaborate with leading innovators and researchers. Our leadership team is focused on strategic growth, operational excellence, and expanding our role as a trusted partner in the global biopharmaceutical supply chain.

KORU designs and manufactures easy-to-use infusion systems for large volume therapies (10+ ml). Our proven, preferred Freedom Infusion Systems consist of two syringe driver options to accommodate a variety of syringes, tubing and subQ needles. Let us assist with the planning and execution of your large volume subcutaneous drug delivery! To learn more, please visit www.korumedical.com

For pharma customers worldwide, Aptar Pharma is the go-to drug delivery expert, from formulation to patient, providing innovative drug delivery systems, components and active material solutions across the widest range of delivery routes. Aptar Digital Health solutions help improve the patient treatment experience and Aptar Pharma Services help accelerate and derisk the drug development journey. To learn more, visit www.aptar.com/pharmaceutical

Ashland is a focused additives and specialty ingredients company serving customers in pharmaceuticals, food and beverage and other consumer and industrial markets. Approximately 2,960 passionate, tenacious solvers – from renowned scientists and research chemists to talented engineers and plant operators – thrive on developing practical, innovative and elegant solutions to complex problems for customers in more than 100 countries.

Cambridge Consultants (CC) is the deep tech powerhouse of Capgemini. Deep tech is a mindset, a bold strategy that harnesses radical science and engineering to achieve things no-one else can. It delivers transformative business value and growth for our clients, who gain defendable commercial and operational advantage from new-to-the-world products, services and processes that they own. We overcome the ultimate business challenge: turning something that doesn’t yet exist into a reality. Our advice is built on practice, with over 750 scientists, engineers, designers and consultants working globally across more than 20,000 sq m of state-of-the-art R&D facilities. As part of Capgemini Invent, CC is backed by 340,000+ Capgemini team members in more than 50 countries.

Curia works with sterile APIs, potent and cytotoxic compounds, and controlled substances – from clinical to commercial scale – at four sterile drug product facilities. Our expertise includes modality agnostic, first principle formulation development designed around target product profile. Curia support the development of solutions, suspensions, emulsions, lipid nanoparticles, and lyophilized dosage forms for various formats, including vials, pre-filled syringes, and cartridges.

For more information please visit https://www.delsitech.com/

Flex is the manufacturing partner of choice that helps a diverse customer base design and build products that improve the world. Through the collective strength of a global workforce across 30 countries and responsible, sustainable operations, Flex delivers technology innovation, supply chain, and manufacturing solutions to diverse industries and end markets. Flex’s health solutions business focuses on medical device and drug delivery design, development and manufacturing solutions for pharmaceutical and medtech companies, including extensive work in injection pens, autoinjectors, wearable pumps and smart inhalers. Our approach is supported by FDA-registered and ISO 13485 compliant and ISO 11608-1 accredited facilities, with a world-class single quality system across sites. For more information, visit www.flex.com

GSK is a global biopharma company with a special purpose – to unite science, technology, and talent to get ahead of disease together – so we can positively impact the health of billions of people and deliver stronger, more sustainable shareholder returns – as an organization where people can thrive. Getting ahead means preventing disease as well as treating it, and we aim to positively impact the health of 2.5 billion people by the end of 2030. To learn more, please visit https://www.gsk.com/en-gb/

Halozyme’s ENHANZE® drug delivery technology is based on our patented recombinant human hyaluronidase PH20 enzyme, rHuPH20, which locally degrades hyaluronan (HA) in the subcutaneous (SC) space. This allows for increased dispersion and absorption of co-administered therapies. ENHANZE technology degrades the HA around the injection site allowing large volumes (up to 300-600 mL) to be delivered in a single subcutaneous injection. Large volume injections may allow some biologics and small-molecule drugs that are administered intravenously to be delivered subcutaneously potentially providing an improved patient experience by decreasing infusion times or reducing the need for multiple injections. For more information, visit: https://halozyme.com/

Haselmeier, the drug delivery device business of medmix, designs, develops and manufactures advanced drug delivery systems, such as pen injection systems and autoinjectors since more than 100 years. With its broad portfolio of technologies and services, Haselmeier delivers user-friendly injection systems that enable patients to self- administer their medication reliably and accurately. Haselmeier is known for its excellent and long-standing track record of providing these innovative drug delivery devices based on its proprietary IP business model. The company collaborates closely with its customers in the pharmaceutical and biopharmaceutical industries. Medmix, with its precision injection molding capabilities and expertise in liquid micro-dosing, plus financial strength and global footprint, helps Haselmeier accelerate innovation in healthcare. For more information, visit www.haselmeier.com

For more information please visit https://www.identiv.com/iot/industries/pharma-and-healthcare

Intrepid Labs accelerates drug formulation using AI, automation, and deep pharmaceutical expertise. Our proprietary platforms combine automated experimentation and machine learning to rapidly design, optimize, and characterize drug products. We partner with pharma and biotech to solve complex formulation challenges. Founded in 2023, Intrepid is building a data-driven, scalable, and patient-focused future for drug development.

Kymanox is a life science professional services organization that offers engineering, scientific, compliance, and project management support to companies exclusively in the biotechnology, pharmaceutical, medical device, and combination product industries. Kymanox helps clients navigate commercialization challenges that arise throughout a product’s life cycle. To learn more, visit www.kymanox.com.

With 40+ years’ experience in drug delivery systems—autoinjectors, inhalers, wearables, and digital solutions—PA supports partners from design to market. Our integrated team and advanced labs excel in device innovation, connectivity, test equipment, device strategy, and combo product support to overcome complex challenges and deliver patient-focused solutions.

PCI is your world leading CDMO, providing clients with integrated end-to-end drug development, manufacturing, and packaging capabilities that increase their products’ speed to market and opportunities for commercial success. PCI brings the proven experience that comes with more than 90 successful product launches each year and over five decades in the delivery of CDMO services. We currently have 35 sites across seven countries (Australia, Canada, U.S., Ireland, UK, Germany, and Spain) and over 7,500+ employees that work to bring life changing therapies to patients. Leading technology and continued investment enable us to address global drug development needs throughout the entire product lifecycle – from manufacturing capabilities through clinical trial supply, commercialization and beyond. Our clients view us as an extension of their business and a collaborative partner, together, delivering life changing therapies.

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world’s best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. Learn more at www.pfizer.com

Since 2003, PharmaCircle has been providing in-depth pharma intelligence, formulation and drug delivery analysis, and supply chain insights to the life sciences industry. PharmaCircle will be showcasing some of our intelligence solutions at PODD 2025, including:

- Partnership Explorer evaluates unpartnered pharma innovation opportunities and potential strategic partners from around the world.

- Formulation Plus provides data-rich insights into critical formulation parameters, including tables detailing maximum excipient amounts per admin and per day by route of administration, and excipient amounts in percent across all dosage forms and delivery technologies with links to comprehensive excipient records.

- Drug Delivery Technology Reviews – 17 research reports, each updated annually and providing a detailed assessment of the technology space and comparative analysis of legacy and next generation drug delivery technologies/devices. Pipeline Dynamics analyzes the global drug, biologics and vaccine development landscape, charting 10+ years of pharmaceutical pipeline trends and tracking when programs moved to clinic.

PharmaCircle curates vast amounts of pharma and device industry data into due diligence level intelligence that is comprehensive and reliable, and provides concierge-level support to help our clients fully leverage the value of this information.

For more information, visit our booth at PODD or www.pharmacircle.com.

Portal Instruments is a MedTech company pioneering next-generation drug delivery technologies. Spun out of MIT, Portal is developing a cost-effective, reusable injection platform for biologics, including GLP-1s. The NEXUS smart auto-injector is fully reusable, automates the injection process, and delivers a best-in-class user experience. It also features seamless connectivity through an AI-driven app that supports patients and engages stakeholders throughout the treatment journey. For pharmaceutical partners, NEXUS offers a highly cost-effective and rapid deployment model. The device never comes into contact with the drug, eliminating the need for reformulation or repackaging. All personalization and therapeutic adaptability are managed through software, enabling rapid iteration and customization without changes to the physical device.

Samyang is a multinational conglomerate founded in South Korea in 1924, operating across diverse sectors including Biopharmaceuticals, Food, Chemicals, Packaging, and Cosmetics. Over the past decades, Samyang has built a strong foundation in drug delivery systems, leveraging its expertise in biodegradable polymers and polymeric micelle formulation technology. This dedication has led to the successful commercialization of modified anti-cancer generics and medical devices, earning global recognition for quality and safety. Currently, our primary focus is on the development of SENS™ (Selectivity Enabling Nano Shell) — a novel drug delivery platform designed for tissue-selective delivery of nucleic acid therapeutics. SENS™ is uniquely composed of biodegradable polymers and newly discovered cationic lipids. By adjusting composition and fine-tuning formulation processes, SENS™ enables targeted delivery of mRNA to specific tissues (e.g., spleen, lung, muscle, liver) while offering superior safety profiles that support repeat dosing. One of our key innovations, NanoReady, is a proprietary, ready-to-use SENS™ formulation. This pre-made nanoparticle system can be easily combined with mRNA immediately before administration, streamlining process development, reducing time-to-patient, and enabling personalized cancer vaccines. Through active collaboration with global partners, we are expanding our SENS™ platform across a range of mRNA-based therapeutics—including prophylactic and therapeutic cancer vaccines, protein replacement therapies, gene editing medicines, and more. We are actively seeking strategic partnerships with drug developers aiming to bring RNA therapies into the clinic. By combining their therapeutic innovations with our validated delivery modalities, we can enable safe and selective targeting, maximize clinical impact, and deliver novel therapies to patients.

We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across some 100 countries, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions. Sanofi’s mRNA Center of Excellence (CoE) pursues the development of new mRNA vaccine candidates to address the long-standing challenges in cancer, immune-mediated diseases, and rare diseases, focusing on thermostability and tolerability. For more information, visit www.sanofi.com

Windgap Medical is imagining the future of reconstitution devices. Our autoinjector platforms simplify, automate, and speed up the delivery of difficult-to-mix drugs, freeing patients, families, and potential cures from the limitations of current medical delivery technology. We are a proud industry leader in self-administration devices that consider the needs of patients first when delivering complex injectables. To learn more, visit https://windgapmedical.com/

For more information please visit https://algipharma.com/

Altaviz is the global leader in designing gas-powered delivery systems. Learn how to harness gas-power for delivery of High Viscosity / High-Volume biologics and challenging drug delivery applications with the AltaVISC High Viscosity / High-Volume Auto-Injector; one of a portfolio of Altaviz gas-powered drug / implant delivery technologies. To learn more, please visit www.altaviz.com

ARx custom develops and manufactures transdermal patches and oral/transmucosal thin film delivery systems for unique drug delivery and patient needs. Our drug delivery technologies expand delivery possibilities for active pharmaceutical ingredients with tailored drug delivery profiles that meet the therapeutic needs of the patient with rapid onset or controlled release, all while enhancing compliance, bioavailability, and avoiding adverse events associated with the 1st pass metabolism. We partner to improve drug delivery at any stage in drug development, from product concept & feasibility assessment through commercial production.

Ascendia Pharmaceutical Solutions is a specialty CDMO that provides custom formulation development, analytical support, and GMP manufacturing for both small molecule and biologic drug products. Our experts deliver sophisticated formulations to enhance bioavailability, solubility and stability, while reducing toxicity using GRAS (Generally Recognized As Safe) materials and four proprietary nanotechnology platforms – NanoSol®, EmulSol®, AmorSol® and LipidSol®. Ascendia offers its aseptic and non-aseptic manufacturing services to biotech and pharmaceutical companies who seek a CDMO partner that is steeped in Socratic process for their formulations. As candidates advance from preclinical and early clinical development to late-stage clinical trials and beyond, Ascendia provides efficient scale-up for oral, injectable and transmucosal/ophthalmic programs. For more information, visit AscendiaCDMO.com.

Battelle is a unique, non-profit, service-oriented organization dedicated to solving the world’s challenges for the betterment of humankind. Within the field of drug delivery, we leverage our extensive experience in the design, engineering, and commercialization of drug delivery devices with specialized knowledge in materials, formulation, pre-clinical research, and user research to create solutions preferred by all stakeholders (clinicians, patients, and project sponsors). Connect with us to learn more about our 95-year heritage of innovative products and discuss what new challenges we can take on together. Learn more at www.battelle.org/health

Bionanopharma, a high-tech drug delivery company majority-owned by Insud Pharma, operates a unique GMP-certified facility with industrial-scale capacity from early-stage development to commercial manufacturing. Our proprietary room-temperature processing enables high-concentration mAb formulations, enhances bioavailability of BCS Class II–IV molecules, and supports customized release profiles across diverse administration routes: SC, oral, nasal, inhalation, LAI, transdermal, sublingual and ophthalmic patches.

Captisol is a derivatized beta cyclodextrin used in 16 FDA-approved products to date, including VEKLURY® (remdesivir) and KYPROLIS®️ (carfilzomib) to help solubilize & stabilize difficult to deliver molecules. Made by CyDex Pharmaceuticals (a Ligand Company), Captisol is the leading pharmaceutical-grade sulfobutylether beta-cyclodextrin (SBECD), with an excellent record of safety and consistency. Captisol has been used in therapeutics across many routes of administration, including parenteral, oral, subcutaneous, ophthalmic, nasal, inhalation, and dermal. It is prepared by an all-aqueous process and distributed world-wide.

Focusing on optimizing drug performance through delivery, Celanese has a patented drug delivery platform, VitalDose® , that addresses a variety of formulation challenges to achieve the desired release profile for your drug. The VitalDose® technology is focused on providing innovative, long-acting solutions for localized and systemic delivery for the minimization of interventions, reduction of adverse effects, and optimization of efficacy. 

The platform has been approved for use in numerous pharmaceutical and medical device applications and Celanese works closely with partners to create innovative, sustained-release implant therapeutics for the continuous delivery of a wide range of drug types.  While we have a long history of success with small molecule drugs, our current focus is on enabling the delivery of complex biologics, RNA, and peptides for months to years of therapy.  We are actively supporting marketed products and development programs in Oncology, Ophthalmology, CNS disorders, Women’s Health, Cardiovascular Diseases, Rare Diseases, Endocrinology, Infectious Diseases and Osteoporosis.  To learn more about our drug delivery applications, visit www.vitaldose.com

In addition, Celanese has a wide range of high-performance polymers and thermoplastics ideal for innovative medical devices, orthopedics, advanced surgical instruments, connected devices and more.  To learn more about polymers for medical devices, visit http://www.celanese.com/applications.

Our purpose is to optimize the potential of injectable drugs that have emerging and hard-to-address delivery needs. We do this by designing, developing and supplying innovative, flexible drug delivery device platforms. Our growing portfolio addresses compelling problems, including microliter dosing, viscous drug delivery, multi-dosing, variable dosing and minimizing drug waste. To learn more, please visit www.congruencemed.com

Corbion Biomaterials is a leading supplier of GMP-grade bioresorbable polymers designed specifically for drug delivery applications, including long-acting injectables (LAIs). Our PURASORB® portfolio offers a proven and versatile platform, with tunable properties that support the controlled release of APIs over defined timeframes, from weeks to years. We offer both off-the-shelf and custom polymer solutions, enabling precise alignment with your target product profile and streamlined development from design to scale-up. Learn more at www.corbion.com.

DFE Pharma, a world leader in providing essential excipients for inhalation and oral solid dose applications for decades, has expanded its presence into the biopharmaceutical market. In addition, we offer a purification step integrated into manufacturing process to enhance the product quality and consistency, strengthening supply chain security as product quality is not affect ed by raw material variations. For more information, visit https://dfepharma.com/

As innovators in nutrition, health, and beauty, we reinvent, manufacture, and combine vital nutrients, flavors, and fragrances for the world’s growing population to thrive. 

In the Biomedical division, we serve as a committed partner in driving sustainable innovation in healthcare, from spark to solution. Our biomaterial products, customized solutions and expert services are recognized for their unmatched quality, reliability, and performance worldwide. 

Together, we bring progress to life every day, everywhere, for billions of people. To learn more, visit dsm-firmenich.com/biomedical

Elcam Drug Delivery Devices (E3D™) is a subsidiary of Elcam Medical™, an Israel-based group with 40 years of experience in the development, manufacturing and global distribution of medical devices. E3D is focused on the design, development, manufacturing and supply of injectable drug delivery devices for self-administration and use in non-clinical environments. Its broad technology portfolio encompasses devices suitable for drugs in a range of primary containers – including auto-injectors, on-body delivery systems, and smart devices with wireless connectivity.

Enable Injections is a global healthcare innovation company committed to improving the patient treatment experience through the development and manufacturing of enFuse, a wearable drug delivery platform that is designed to subcutaneously deliver large volumes of therapeutics. Enable is working with a number of pharmaceutical partners planning for joint commercial launch of their therapies in combination with the enFuse technology. The enFuse technology received its first combination product U.S. FDA approval in 2023 and CE Mark approval in Europe in 2025.

Envoya is a pioneering biotechnology company specializing in the development of non-lipid, polymer-based nanoparticles for gene delivery. Leveraging cutting-edge research and innovative technology, Envoya has successfully crafted nanoparticles that stand out due to their exceptional safety and efficacy profiles. Envoya is at the forefront of a transformative wave in gene therapy, offering solutions that promise to overcome some of the most persistent challenges in the field. Their innovative use of FDA-approved, non-lipid polymers to create non-immunogenic nanoparticles with high payload encapsulation and transfection efficacy represents a significant leap forward. With a firm commitment to excellence and innovation, Envoya is poised to make a substantial impact on the future of medicine, bringing forth new possibilities for personalized and effective gene-based treatments. For more information, visit https://www.envoyabio.com/

Evonik Industries, a global leader in specialty chemicals, provides drug delivery technologies, API manufacturing, intermediates, ingredients for nutraceuticals, amino acids and derivatives. Drug delivery technologies include modified release formulation development services, solubility enhancement, functional excipients, bioresorbable polymers, lipid nanoparticle mRNA delivery, and GMP manufacturing for oral and parenteral formulations. Advanced delivery technologies for extended-release parenterals are offered for small molecules, peptides, proteins, antibodies, and nucleic acids. Learn more about us at www.evonik.com/healthcare.

G2GBIO is a clinical-stage biotech company specializing in long-acting injectables of various small molecule and peptide drugs. Its proprietary platform technology, InnoLAMP, enables the mass production of homogeneous microsphere with high drug loading (~60% for small molecules and ~50% for for peptides), improved bioavailability, and less injection site reactions.

HCmed is a CDMO company focused on inhaled drug-device combination by bringing significant value to pharma partners through a cost efficient and risk minimized pathway with our exclusive drug delivery platform of mesh nebulizers. Our mission is to create products that are highly integrated for affordable-best-quality.

InnoCore Pharmaceuticals is a biopharmaceutical formulation company specialized in the development of complex parenteral sustained release formulations. By using our proprietary biodegradable polymers we can make microspheres, erodible gels and solid implants resulting in long acting and minimally invasive drug delivery products of small, medium sized (peptides) and large (proteins, antibodies) drug molecules. Learn more at www.innocorepharma.com.

InnoMedica is a ground-breaking Swiss biotech with the mission to enhance therapies for diseases with great unmet therapeutic needs through further development and new applications of our patented nanotechnology. Our nanotechnology platform is based on particularly small and uniform liposomes with an intelligent surface structure, making medical use of the body's natural logistics for the distribution of molecules. This allows the packaging of active ingredients which cannot reach the target in sufficient quantities or cause severe side effects when applied in high dosages. InnoMedica has applied our proprietary delivery platform to develop treatments for diseases and conditions in different therapeutic areas, with the objective of significantly improving the standard of care for patients with unmet needs.  For more information, visit https://innomedica.com/en/

Inventage Lab is a clinical-stage South Korean biotech developing long-acting injectables and nucleic acid delivery therapies using its proprietary microfluidics-based platforms, DrugFluidic® and GeneFluidic®. With KGMP-certified facilities and multiple LAI programs in clinical stages, the company actively seeks global partners for licensing and co-development.

At Jabil, we are proud to be a trusted partner for the world's top brands, offering comprehensive engineering, manufacturing, and supply chain solutions. With over 50 years of experience across industries and a vast network of over 100 sites worldwide, Jabil combines global reach with local expertise to deliver both scalable and customized solutions. Our commitment extends beyond business success as we strive to build sustainable processes that minimize environmental impact and foster vibrant and diverse communities around the globe. Discover more at www.jabil.com.

Key Tech is an end-to-end product development firm specializing in the design of complex electromechanical devices and systems for medical applications. It is 100% employee owned and located in downtown Baltimore (MD, US). Key Tech employs 75 engineers and designers focused on transforming complex technologies into simple, intuitive solutions. For more information, please visit https://www.keytechinc.com/

As a purpose-fueled drug delivery CDMO, we leverage our specialist injectable, inhalation and dermal expertise to accelerate your product’s journey and make tomorrow’s possibilities a reality.

From development to commercial manufacturing and beyond, amplify your product’s impact with our exceptional-by-design CDMO solutions.

Latest News

Our Bridgeton facility has over 155,000 sq. ft. of dedicated aseptic operations space, including state-of-the-art laboratories and formulation suites, alongside almost 11,000 sq. ft. of fill suites to ensure the highest levels of quality and patient safety.

Lipoid is a major international supplier of phospholipids for usage as pharmaceutical excipients. We have a strong focus on quality. Our products are GMP, many have Drug Master Files, and many are utilized in commercial drug products. Lipoid is also known for its expertise in bulk production. This allows us to keep prices affordable and allows you to use identical material in both your first small scale preclinical batch and your future commercial batches. Phospholipids are most known for their use in parenteral applications, such as injectable emulsions and liposomes. They are also excellent excipients in oral, pulmonary, and topical applications, among others. In these applications they improve the bioavailability, solubility, and permeability. For more information, visit https://lipoid.com/en/

We CARE. We CREATE. We DELIVER. The driving philosophy behind LTS LOHMANN Therapie-Systeme AG. As a trusted technology partner for the pharmaceutical industry, we develop and manufacture innovative drug delivery systems such as Transdermal Patches (“TTS”) and Oral Thin Films (“OTF”) as well as wearable drug delivery devices (“OBDS”). LTS´ commercial offering encompasses more than 20 marketed products and a diverse pipeline of more than 40 development projects targeting multiple disease indications. LTS’s innovation pipeline contains both partner-funded and proprietary, LTS-funded projects. With its SorrelTM wearable drug delivery platform LTS offers patient friendly solutions for complex drugs delivery at home. To learn more, please visit www.ltslohmann.com

Mitsubishi Gas Chemical (MGC) is a leading company in the field of oxygen barrier and absorbing polymers. Based on these technologies and experiences, MGC launched new multilayer plastic vial & syringe named OXYCAPT™ in 2019. It has achieved excellent oxygen, carbon dioxide & ultraviolet (UV) barrier, high water vapor barrier, very low extractables, high pH stability, low protein adsorption, high transparency, high break resistance, easier disposability, lighter weight, etc. OXYCAPT™ consists of three layers. The drug contact layer and the outer layer are made of cyclo-olefin polymer (COP), and the oxygen barrier layer is made of MGC’s novel polyester. The oxygen & carbon dioxide barrier of OXYCAPT™ vial is about 20 times better than that of COP monolayer vial. OXYCAPT™ also provides an excellent UV barrier. While about 70% of 300 nm UV light transmits through glass and COP, only 1.7% transmits through OXYCAPT™. OXYCAPT™ vial is produced by co-injection blow-molding technology. MGC has also developed inspection methods for testing the oxygen barrier layer. All of the containers are fully inspected by state-of-the-art inspection machinery. MGC can offer ready-to-use (RTU) vials in tray or nest & tub formats. The vials are mainly sterilized using gamma rays. There are 2, 6, 10 and 20 mL variants for vials. OXYCAPT™ vial is especially suitable for biologics and cell & gene therapy products stored at deep-cold or cryogenic temperature. It can maintain container closure integrity (CCI) under such harsh conditions and prevent carbon dioxide permeation generated from dry ice and nitrogen permeation from liquid nitrogen. As the carbon dioxide permeation usually causes pH shift and nitrogen permeation causes over-pressure in headspace, MGC believes OXYCAPT™ is an ideal solution for the drugs stored in dry ice and liquid nitrogen.

PharmaShell® is Nanexa’s novel drug delivery system. PharmaShell® achieves a high drug load, low injection volume, with excellent in-situ stability, controlled burst release and depot length. This is achieved by formulating a suspension containing coated drug particles with a controlled solubility of the coating. As the coating dissolves, the drug is released in a pre-defined manner over time. To learn more, visit https://nanexa.com/

Incorporated in 2003, Nanobiotix is headquartered in Paris, France and has been listed on Euronext Paris since 2012 and on the Nasdaq Global Select Market in New York City since December 2020. The Company has subsidiaries in Cambridge, Massachusetts (United States) amongst other locations. Nanobiotix has created three nanophysics-based technology platforms with multiple product applications: 1) nano-radioenhancers to help millions of patients receiving radiotherapy; 2) nanoprimers to overcome challenges with liver clearance and redefine the way drugs can be designed bioavailability; and 3) nanoparticles for disorders of the central and peripheral nervous system. For more information, visit www.nanobiotix.com

Working, creating, together. We are convinced that in a world where new medicines, new practices and better therapeutic outcomes are constantly being sought, collaboration is the only way to efficiently reach these goals. Nanomi has developed the unique Microsieve technology that adds value to drug development programs of others. The technology is applicable to a wide range compounds and provides the most advanced solution for manufacture of uniform monodisperse biodegradable microspheres and nanoparticles for long-acting release medicines. Nanomi’s pioneering approach in drug delivery has set new benchmarks in the industry, and this award serves as a motivation to continue its mission to revolutionize healthcare. Nanomi is open to partnerships.

Nanomol Technologies offers tailored nanomedicine development and manufacturing solutions by our patent protected, green and robust DELOS technology, in addition to advanced GMP particle characterization services. DELOS nanocarriers stabilize, protect and improve the performance of APIs -from small chemical molecules to biologics, including peptides, proteins and nucleic acids, enabling new administration routes and enhanced or novel drug products.

For more information, visit https://nanomol-tech.com/

Nissha Medical Technologies - Isometric is a vertically integrated provider of micro molding and automated assembly solutions, with a focus on high-precision applications in the medical device and drug delivery sectors. Vertical integration enables comprehensive control over precision (controlling microns), cost and speed. 

Our expertise provides solutions tailored to various drug delivery devices. We are able to mold thin-walled components—including needle tips and cannulas—using advanced, challenging materials. This capability not only addresses the technical demands of modern drug delivery but also supports efficient production at scale, facilitating precise and reliable therapeutic delivery.

Nissha Medical Technologies is a global CDMO offering design, development and manufacturing solutions for complex single use minimally invasive surgical devices, clinical wearables and clinical accessories.

Nitto BioPharma’s DDS Platform is composed of proprietary biodegradable LNPs that efficiently deliver nucleic acid payloads into target cells for activity. Key features: • Enable passive or active targeting to specific organs or cells • Ensure high level of activity while exhibiting the best performance for tolerability and safety • Clinically-tested formulations for liver and lung delivery for licensing • Effectively and safely deliver diverse nucleic acid payloads (siRNA, sRNA, miRNA, mRNA, circular and SA-RNA, DNA) to the liver and extra-hepatic organs (lung, T-cells, etc.)

NOF CORPORATION is the leading commercial supplier of drug delivery products such as activated PEGs, lipids and ultrapure Polysorbates 80. Our cutting edge products include Pendant type single molecule PEG linkers for ADCs and SS-lipids for nucleic acid and gene delivery. For more information, visit www.nofamerica.com

Noxilizer is a fast-growing medical technology company that provides ultra-low temperature nitrogen dioxide sterilization that offers many benefits over traditional sterilization methods. Our customers are the leading global pharmaceutical, biotech and medical device companies developing the next generation of products. Noxilizer products and services include: feasibility studies, contract sterilization, consulting, sterilization equipment, consumable product line, and customer and technical service. Noxilizer’s headquarters are in Hanover, MD. To learn more, please visit https://noxilizer.com/

Oakwood Labs specializes in the development and aseptic manufacturing of sustained-release microsphere products, ranging in duration from weeks to one year, through the use of our patented Chroniject™ technology. Oakwood’s FDA approved cGMP aseptic facility enables partners the ability to bring products from feasibility concepts to successful commercialization. To learn more, visit https://oakwoodlabs.com/

For more information please visit https://www.persist-ai.com/

PharmaJet’s mission is to enable greater access to life improving pharmaceuticals. We are committed to helping our partners realize their research and commercialization goals while making an impact on public health. PharmaJet’s Needle-free Injection Systems provide increased vaccine effectiveness, a preferred patient and caregiver experience, and a proven path to commercialization. They are also safe, fast, and easy-to-use. The Stratis® System has U.S. FDA 510(k) marketing clearance, CE Mark, and WHO PQS certification to deliver medications and vaccines either intramuscularly or subcutaneously. The Tropis® System has CE Mark and WHO PQS certification for intradermal injections. For more information visit www.pharmajet.com.

PSN Labs is your full-service partner for engineering and product development, specializing in drug delivery solutions. From concept to commercialization, we manage every step, ensuring risk mitigation and optimization through virtual and physical processes. Our ISO 17025 Testing Lab offers biocompatibility testing, drug stability assessments, and regulatory consulting. With ISO 13485-certified molding facilities equipped with cleanroom capabilities, we streamline manufacturing and functional prototyping. Consolidating services with PSN Labs saves time, costs, and ensures the highest quality standards are met, providing a hassle-free experience for our clients. For more information, visit https://www.psnlabs.com/

QurCan Therapeutics, a University of Toronto spin-off biotech company, is developing the next wave of CNS-tarted genetic medicine. The team has engineered a proprietary nanoparticle-based CNS-penetrating platform, C-TERP, that facilitates delivery of nucleotides (ASO, siRNA, mRNA, DNA) to the brain. Its value has been further validated through multiple strategic partnerships with leading pharma companies as well as pre-clinical settings. Leveraging C-TERP technology, the company is building a pipeline of targeted genetic medicines for the treatment of rare neurological diseases.

Re-Vana Therapeutics is a Transformative Ocular Therapeutics company, developing Sustained Release 6 Months+ Biologics with our proprietary biodegradable photo crosslinked technologies. To learn more, please visit https://www.revanatx.com/

For more information please visit https://www.rippletherapeutics.com/

The Sanner Group is a global Contract Development and Manufacturing Organization (CDMO), dedicated to delivering high-quality, finished drug delivery devices for its customers. With over 750 employees and cutting-edge manufacturing facilities across the EU, US, and China, Sanner Group excels in turning complex medical device projects into reality. Their expertise extends across a wide range of critical drug delivery systems, such as autoinjectors, infusion pumps, inhalers, safety syringes, and connected devices. The company's innovative approach to device design and development is further strengthened by its Design Centres of Excellence in the US (Gilero) and UK (Springboard), which drive cutting-edge solutions for customers. For more information, visit https://www.sanner-group.com/

Sartorius BIA Separations is developing best-in-class analytical and preparative chromatographic solutions for Gene Therapy and Vaccines spaces. CIM column, utilized in hundreds of clinical batches, are setting the standard of manufacturing highly complex AAV, Adeno, pDNA, mRNA, VLP, Viruses, Viral Vaccines, LNP, Exosomes and bacteriophages products. PATfix in-process LC system with multidetector set-up aims to enhance bioprocess understanding and implies a holistic approach to ensure that quality is built into products by design.

The SatioPatch™ Platform decentralizes care by Transforming Workflow for diagnostics, drug delivery and biometrics integration. This adhesive patch platform is being developed for drug and vaccine delivery with a reusable applicator and low-cost disposable with pressure sensors. The platform is designed to provide stable (through adhesive patch) and controlled (through motors) delivery to match the needs of a wide range of drugs and to improve the experience for chronic disease patients with recurring injections. Radical innovations in workflow include a remote tele-injection capability (video, biometrics, remote control, go/no-go sensors, EHR transmission) and a fully automated delivery through the intradermal (1ml) or subcutaneous route of administration at Therapeutic Dose levels. Products not yet approved in US or other territories.

Secant Group’s innovative and patent-protected Hydralese® polymer platform provides an elastomeric and bioresorbable polymer that enables long-acting drug delivery. Secant’s material experts specialize in developing custom finished dosage forms for the delivery of a  variety of API’s. We have the expertise to support pharmaceutical payload delivery development to enable novel, patient-centric therapies that positively impact health. Learn more at secant.com/drug-delivery

SiCare Bio is enabling the next generation of nano-therapeutics through its novel drug delivery platform. Underpinning SiCare’s platform is its precision nanoporous silicon dioxide particles which are customized for specific molecules and release profiles. SiCare is working with industry partners on both long acting injectables and intracellular release applications.

SMC Ltd. provides “end-to-end” integrated services for clinical and commercial manufacturing of drug delivery combination products, and specializes in the development of patient-centric autoinjectors for challenging drug formulations including high viscosity/high volumes. Visit us at www.smcltd.com.

Founded in 1949, Stevanato Group is a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. The Group delivers an integrated, end-to-end portfolio of products, processes and services that address customer needs across the entire drug life cycle at each of the development, clinical and commercial stages. Stevanato Group’s core capabilities in scientific research and development, its commitment to technical innovation and its engineering excellence are central to its ability to offer value added solutions to clients. For more information, visit www.stevanatogroup.com

Surf Bio is a preclinical biopharmaceutical company transforming the delivery of antibodies and biologics.

Powered by a proprietary polymer platform, our SnapShot™ technology enables ultra-high concentration formulations (up to 600 mg/mL) and subcutaneous delivery of doses up to 1,000 mg via standard autoinjectors, with no reconstitution, device redesign, or specialized manufacturing. SnapShot formulations support longer dosing intervals, at-home administration, and a dramatically improved patient experience.

To learn more, visit https://www.surf.bio

Suttons Creek is pharma’s device team. Any life sciences company going to market with a drug delivery system needs a device team experienced in combination products working alongside their drug team. That device team includes specialists in areas like quality, regulatory, vendor selection and management, systems engineering, risk management, clinical development, human factors, and commercialization. Suttons Creek has over 650 years of combined experience and 120+ combination product projects under its belt. Our talent pool of subject matter experts specializes in all device-related aspects of the combination product lifecycle, from strategic planning through development to launch and postmarket activities. Our history of success proves that hiring our experienced device team results in faster time to market, reduced risk, improved patient experience and adherece, and lower overall cost (higher profit). For more information, visit https://suttonscreek.com/

Syntis Bio is a clinical-stage biopharmaceutical company developing oral therapies that harness the small intestine’s unique biology to provide more accessible, effective and sustainable solutions across the healthcare spectrum, from rare genetic disorders to the world’s most prevalent conditions. Syntis is rapidly advancing a pipeline of oral therapies engineered for targeted activity in the small intestine, the body’s nexus for metabolic control, digestion and drug absorption. Alongside its lead obesity program, SYNT-101, the company is advancing a portfolio of therapies targeting orphan metabolic diseases and intestinal-related disorders. Syntis is headquartered in Boston, MA.

Team Consulting is a world-class partner in medical device design and development. Working with leading pharma companies to innovative start-ups, we apply the latest approaches in design theory, engineering ingenuity and human factors to create user-centered solutions for your drug delivery needs. For more information visit https://www.team-consulting.com/

As Part of Terumo Medical Care Solutions, the Pharmaceutical Solutions Division develops patient-oriented parenteral delivery solutions for therapeutic performance and safety. Globally trusted for quality and precision, we offer pharmaceutical and medical device manufacturers around the world comprehensive product design and development services. We have decades of experience collaborating with pharmaceutical companies from the earliest phases of drug development to product commercialization to optimize critical aspects of parenteral drug delivery. Innovation and creativity are central to our value proposition. Our expert teams lead the industry in developing and manufacturing advanced, high-performing infusion and injection technologies, including CDMO services for all parenteral applications. We listen. We question. We deliver. For more information, visit https://www.terumopharmaceuticalsolutions.com/

TesoRx Pharma and its subsidiary, Lipac Oncology, are clinical-stage companies utilizing a novel Neoliposomal™ delivery system. This delivery system addresses significant challenges like poor solubility, low permeability, and systemic toxicity, creating breakthrough therapies. Their primary clinical candidates are for intracavitary carcinomas (Lipac) and oral Testosterone Replacement Therapy (TRT) (TesoRx). TesoRx's TRT bypasses the liver via lymphatic absorption, demonstrating clinically enhanced bioavailability.

Therakind is a UK-based specialty pharmaceutical company that has successfully taken three products through FDA, EMA, and MHRA regulatory approval. It is developing its own dry powder intranasal drugs and collaborating with multiple partners on NCE and repurposing programmes leveraging its IP-protected proprietary DriDose® intranasal delivery technology. The platform enables rapid absorption without injection or breathing coordination and supports single-use and multidose reusable formats.

Trekka Therapeutics has developed CAPRO™, a novel biomaterial platform for drug delivery that overcomes the challenges associated with solubility, stability, loading and controlled release across a range of APIs including small-molecules, biologics (proteins, peptides, nucleic acids, vaccines) and combination drugs. CAPRO polymers are adaptable to various routes of administration and modified release dosage forms. They are also compatible with many existing excipients to form particulates, emulsions, gels and composites while the manufacturing is simple and highly scalable.

TTP is a product development consultancy that has been helping pharma and medical device companies develop new, innovative and marketable drug delivery solutions for over 30 years. This experience encompasses a broad range of respiratory, parenteral and transdermal devices. To learn more, visit https://www.ttp.com/

Veryst Engineering, LLC provides premium engineering consulting services at the interface of technology and manufacturing. We offer PhD+ level expertise in specialized areas across engineering, physics, and materials science disciplines. We help clients around the world optimize product design, improve manufacturing processes, and diagnose product problems. Our methods are based on technical fundamentals – employing grounded knowledge of mechanics, physics, chemistry, material science, electricity and magnetism, and manufacturing to produce practical, useful results. When our clients are stuck on tough product development issues and don’t know where to turn, they reach out to us.

ViaNautis is pioneering precision genetic medicines with polyNaut®, a polymer nanovesicle platform enabling targeted delivery beyond the liver. Our programs span CNS, I&I (autoimmunity), and CF - developing safe, redosable products. Based in Cambridge, UK, we advance partnerships to unlock new therapeutic frontiers.

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites including 25 manufacturing facilities worldwide, West helps support our customers by delivering over 41 billion components and devices each year.

Headquartered in Exton, Pennsylvania, West in its fiscal year 2024 generated $2.89 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com.

Xylome is a genetic engineering company with a focus on high-value and sustainable products for drug delivery and personal care. Our patented lead product is Large Lipid Body (LLB) Technology for hydrophobic active pharmaceutical ingredients. LLB Technology advances the state-of-the-art for particle-based delivery with significant advantages over liposomes and nanoparticles. GMP samples are available and Xylome is using LLB Techology for the development of a new class of antifungal for serious burns. As a metabolic engineering company, Xylome has an advanced platform for the expression of fats and oils, which are produced by precision fermentation of our nonconventional yeast. Our available portfolio and GMP samples include multiple forms of YOIL®️, a very pure, bioidentical replacement for RBD-palm oil.

Ypsomed is the leading developer and manufacturer of injection systems for the self-administration of liquid injectable medications. As the reliable partner of pharmaceutical and biotech companies for more than 40 years, Ypsomed provides tailored selfcare solutions to meet specific needs. Backed by a proven track record, Ypsomed offers the most comprehensive and innovative platform portfolio for pens, autoinjectors, and on-body devices. Delivered with best-in-class execution and ready to integrate with digital health services, these solutions help simplify therapy and improve the quality of life for millions of people living with chronic conditions. Ypsomed is headquartered in Burgdorf, Switzerland, and operates a global network of manufacturing facilities. More than 2,000 employees worldwide are committed every day to making selfcare simpler and easier.

Zephyrus Innovations is a Medical Device company focused on designing and manufacturing cutting-edge drug delivery systems that address unmet safety and regulatory compliance needs - delivering meaningful value for patients and healthcare practitioners. 

Our latest innovation VaporShield is the World’s First direct injection CSTD designed for Subcutaneous / Intramuscular administration of hazardous drugs. VaporShield is a true end-to-end closed system which prevents splattering, spraying and aerosolization of drugs. VaporShield incorporates integrated needlestick injury prevention through auto-disabling needle retraction. Visit our website for more information www.zephyrusinnovations.com

Zephyrus Innovations. Simple Systems for Safer Care.

RheoTek Medical is advancing ultra-precise drug delivery technologies—needle and needle-free—designed to enhance accuracy, consistency, and patient outcomes across immunotherapy, vaccines, and pain management. Our platform addresses the critical need for controlled dosing and predictable delivery, expanding access to life-saving therapies and enabling new treatment possibilities in both clinical and decentralized settings.

Weiss-Aug MedPharma specializes in the manufacturing of high-quality medical device components, assemblies, and finished products. With over 50 years of experience and a deep commitment to quality, we help leading medical device companies bring life-changing innovations to market with speed, accuracy, and full regulatory compliance. Our advanced manufacturing capabilities, robust quality management systems, and engineering expertise make us a trusted extension of your team. Whether you’re scaling a breakthrough device or refining a complex assembly, we provide the technical excellence and responsive service you need to succeed in today’s demanding healthcare environment. With capabilities spanning engineering design and development, precision machining, injection molding, metal stamping and value-added assembly solutions, we provide a flexible engagement model to bring your medical innovations to life. Our ISO-certified facilities ensure the highest standards in quality, traceability, and compliance. Partner with us to accelerate innovation, reduce risk, and deliver exceptional outcomes—because when it comes to patient safety and performance, only the highest standards will do.

3P innovation is a UK-based custom automation company supporting pharma and medical device businesses to develop new products, devices and novel production processes. 3P innovation specialises in aseptic processing and powder/liquid filling technologies, designing and building scalable GMP production solutions, from lab-scale/bench-top machines through to commercial-scale lines. To learn more, please visit www.3pinnovation.com

Established in 2004, Agno Pharma is a leading global CDMO headquartered in Bethlehem, PA, USA. Specializing in comprehensive cGMP manufacturing solutions, we excel in developing and producing regulatory starting materials (RSMs), intermediates, and active pharmaceutical ingredients (APIs). Our capabilities include high potent, sterile, and flow-based APIs, along with complex sterile drug product formulations such as injectable suspensions, emulsions, long-acting implants, and other implantable products. To learn more, please visit http://www.agnopharma.com/

Altek Medical designs, develops and manufactures medical devices with a global footprint across Taiwan, Singapore, Malaysia and China. Altek provides solutions and services with a proven record of product development and manufacturing, spanning from product design, verification, validation to automated manufacturing. Altek specializes in electromechanical design with a combination of mechanical, electronics, optics and software expertise. Altek’s key products include smart drug delivery devices such as autoinjectors, pen injectors, off-body injectors, on-body injectors, and infusion pump that are enabled with wireless connectivity and other advanced technologies.

Amcor is a global leader in packaging solutions for consumer and healthcare products. With industry-leading innovation capabilities, global scale and technical expertise, we help our customers grow and meet the needs of millions of consumers every day. Our teams develop responsible, more sustainable packaging in flexible and rigid formats across multiple materials. Supported by a commitment to safety, ~70,000 colleagues across ~140 countries bring our global capabilities to local customers and provide local access to global brands. Our work is guided by our purpose of elevating customers, shaping lives and protecting the future. NYSE: AMCR; ASX: AMC

Argonaut Manufacturing Services is a leading contract development and manufacturing organization (CDMO) dedicated to supporting biopharmaceutical and combination product innovators with high quality GMP manufacturing services in the areas of formulation, aseptic fill/finish, kitting, device assembly, and distribution. Argonaut’s Aseptic Drug Product Fill/Finish facility is designed for clients in pre-clinical through commercial phase. Find out more by visiting https://www.argonautms.com

In addition to developing demonstration devices and training materials that go beyond just informing to truly educating, Artcraft Health has launched a proprietary technology that helps ensure successful patient onboarding. DemoX™ is an electromechanical autoinjector training device that is designed to deliver a no-fail training experience. It delivers five times as many demo cycles (at least 1,000) as traditional training devices, so clinicians can be better equipped to provide the training their patients need and set them on the right path from the start.

At our ISO13485 certified medical division BAUMANN addresses the unique needs of customers in the medical and pharmaceutical industry. BAUMANN has the know-how to tackle the specific challenges, extraordinary standards, and strict requirements of the industry, and stand as recognized expert. To learn more, visit http://www.baumann-medical.com/

For more information please visit https://www.bbsautomation.com/en

BOC Sciences is a trusted CRO partner specializing in targeted nanodelivery platforms and high-quality components for drug delivery. Our comprehensive portfolio includes PEGs, lipids, phospholipids, small molecule ligands, CPPs, and aptamers—enabling the advanced delivery of small molecule drugs, peptide therapeutics, mRNA, and oligonucleotide-based drugs. With deep expertise in bioconjugation, nanocarrier engineering, and targeted delivery strategies, we offer both catalog and custom solutions to meet the evolving demands of modern therapeutics. BOC Sciences is ISO certified and provides GMP-grade materials suitable for Phase I clinical trials. From early discovery to clinical development, we are committed to accelerating your innovation in targeted drug delivery.

Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, is a leading global innovator in Infusion Care. The company provides patients and healthcare professionals with innovative technologies that support the treatment of diabetes and Parkinson’s disease through subcutaneous therapy. Leveraging Convatec’s industry-leading research and development and manufacturing capabilities, the company continues to develop long-term successful partnerships with pharmaceutical and medical device companies, benefitting patients and progressing chronic care.

Covestro is one of the world's leading manufacturers of high-quality polymer materials and their components. With its innovative products, processes and methods, the company helps enhance sustainability and the quality of life in many areas. For applications such as medication delivery, surgical instruments, electromedical equipment and wound care, Covestro offers dedicated thermoplastics, films, TPU, raw materials for adhesives, foams, and more. For more information, please visit https://solutions.covestro.com/en/industries/healthcare

DALI has been developing drug delivery devices from concept to commercialization for pharmaceutical and medical device companies since 2003. Our injectable drug delivery devices are designed for increased patient compliance to prescribed therapies (by Biologic/Biosimilar/Generic drugs) with greater ease and comfort than ever before. In addition, DALI’s creative and proven injectable drug delivery devices answer patient needs for easy self-administration. For more information please visit https://www.dalimed.com/

DCA is one of the world’s leading product design consultancies, with an exceptional record of developing drug delivery devices from strategy, through technical delivery, to market success. We can provide expert support for device strategy, due diligence, mechanical engineering, connectivity, medical device software, electronics, usability, industrial design, industrialisation support, packaging and instruction design. To learn more, visit https://www.dca-design.com/

H&T Presspart is a world leader and specialist in the design, development and manufacture of drug delivery devices and pharmaceutical components. With 50 years’ experience in partnering with the world’s leading pharma companies we have developed a strong reputation for precision and reliability – critically important when patients’ quality of life depends on our products. To learn more visit www.presspart.com

Harro Höfliger specializes in the development of customer-oriented process and production solutions for pharmaceutical and medical applications as well as market-oriented consumer products. In addition to innovative machine platforms and packaging machines, customized turnkey system solutions for product assembly, processing of web materials, as well as dosing and inhalation technology are the company’s core expertise. The systematically structured portfolio of upscalable test machines and modules, as well as requirement-oriented technology platforms, results from many years of experience and targeted research and development. Thus, Harro Höfliger covers all phases from the laboratory stage to high-performance production. For more information, visit https://hoefliger.com/en/

For over 80 years, we have been delivering high precision injection molds for some of the most successful metered dose inhalers, insulin pens, diagnostic products and other medical drug delivery devices around the world. Our problem-solving mindset, proven track record in the healthcare industry, considerable medical experience and meticulously methodical way of working ensures you the highest quality, process control and traceability needed for your medical products. To learn more, visit www.igsgebojagema.nl

INCOG BioPharma is a fill/finish CDMO providing end-to-end solutions for clinical through commercial phase sterile injectable drug products for the global biopharmaceutical market. Our facility is FDA-approved and Annex 1-compliant and uses the latest technology to provide tailored manufacturing solutions. We fill high-value biologics and peptides into syringes, vials, and cartridges, and offer autoinjector assembly, final packaging solutions, and in-house analytics.

Kenox Pharmaceuticals (Princeton, NJ) is a contract development, manufacturing, and testing organization specializing in nasal, inhalation, and ophthalmic products. We offer early-stage research and development through GMP fill-finish and testing of non-sterile and sterile drug-device combination products for Phase I and II clinical trials. Our unique value lies in our deep expertise, broad experience, and flexibility in managing diverse device technologies, including Soft Mist inhalers, to support innovative drug delivery solutions.

KERN LIEBERS is a global technology leader for the engineering and production of safety-relevant metal components and hybrid assemblies at over 40 locations around the world. Specialized in tailor made SMART SPRINGS and SMART PARTS for specific drug delivery systems. SMART SPRINGS - Customized Intelligent Power Packs Design elements as trigger mechanism for drug administration and enery storage in drug delivery systems. Global manufacturer for all kind of flat springs, wire springs and wave springs. SMART PARTS - Individual High Complex Components Design elements for all kind of safety-relevant functions. Stamped-bent parts, micro-stamped components, assemblies and laser welded parts.

For more information please visit https://www.kimballelectronics.com/

Lesjöfors manufactures and supplies the medical industry with springs and pressings from wire or strip material for disposable medical products, medical equipment and hygiene-related products. We have an expansive network of production plants around the world with exceptional expertise and equipment dedicated to the medical sector. Regardless of the quantity and application, we offer innovative solutions for manufacturing, cleanliness, packaging and automation. Our medical technological high-quality standards are achieved through state-of-the-art production facilities and production technology, a large range of products, use of the latest laboratory technology and certified standards. For more information, please visit https://www.lesjoforsab.com/industries/medical/

Lifecore Biomedical is an integrated CDMO with expertise in specialty formulation, aseptic filling, and final packaging of complex medical devices and injectable pharmaceuticals. Capabilities include: FDA-approved commercial products, highly viscous products (in excess of 100,000 cP), process development, clinical and commercial manufacturing, on-site analytical services, and pharmaceutical-grade sodium hyaluronate production. To learn more, please visit https://www.lifecore.com/

Founded in 1927, Littelfuse is a diversified industrial technology manufacturing company empowering a more sustainable, connected, and safer world. Across more than 20 countries, and with approximately 16,000 global associates, we partner with customers to design and deliver innovative, reliable application solutions. Littelfuse offers an extensive technology portfolio— switches, sensors, TVS diodes, diode arrays, fuses, semiconductors, polymers, ceramics, relays, and more. Serving over 100,000 end customers, our products are found in a variety of health care, electronics, and mobile end markets— everywhere, every day. Littelfuse offers solutions for various health care applications, including auto-injectors or drug delivery pens, Continuous Glucose Monitors (CGM), insulin pumps, and wearable injectors. Discover how Littelfuse components and system modeling can optimize your designs for cost-effective, high-performance medical devices. Visit us at Booth #611 to stay ahead in medical innovation.

Lyophilization Technology, Inc. is a Contract Development and Manufacturing Organization. The company conducts applied research, provides comprehensive scientific services and technical support ranging from developing new freeze-dried products and processes, streamlining operations to improving compliance, and manufactures clinical supplies for freeze dried pharmaceuticals, biologics, diagnostics, biopharmaceuticals and fine chemicals. To learn more, please visit https://www.lyotechnology.com/

Merxin Ltd: We Make Inhalers. We make dry powder inhalers (DPI) and soft mist inhalers (SMI). Our range of soft mist, dry powder and multidose dry powder inhalers are ready to launch your molecules. Our capsule DPI MRX003 is on the market; our SMI MRX004 is the preferred option for both biologics and ultra-low carbon footprint; MRX006 is a multidose “open-inhaler-close” DPI; MRX002 is a see through cannister for HFA/HFO pMDI formulations. We Will Launch You. For more information, please visit www.MERXIN.com. 

A global provider of healthcare manufacturing solutions, MGS provides the right balance to drive vital innovations: robust, vertically integrated global capabilities combined with the strong customer focus and seamless collaboration of an agile partner. That’s why we’re the global healthcare manufacturing partner of choice for today’s leading Pharma, Diagnostic and MedTech companies. For more Information, please visit https://www.mgsmfg.com/

Millstone Medical is a leading CDMO providing end-to-end solutions for combination device & drug packaging, assembly, testing and distribution. Founded in 2000 and headquartered in Massachusetts, Millstone Medical is your single source solution for clinical trials of combination products and speed to market. Our ISO 13485 dedicated class 7 clean rooms, innovative technology and skilled teams will guide your device from development to market. Our certified laboratories provide product, packaging and environmental testing to our biopharmaceutical customers 60% faster than industry norms. To learn more, please visit www.millstonemedical.com.

German CDMO operating in biotech and pharmaceuticals fields with core expertise in nanotechnologies & particle engineering. Our R&D labs and cGMP-manufacturing site provide end to end solutions from concept to clinical batch manufacturing including development, transfer and GMP production of nano- and microparticle formulations. We also provide Quality Control, Batch release and Stability studies. To learn more, please visit https://mybiotech.de/

Nelipak® is a leading of rigid and flexible packaging solutions for medical device, diagnostic, and pharma drug delivery and. To support the development of innovative sustainable packaging solutions, Nelipak offers in-house design, prototyping, and other value-added services as well as a line of tray sealing equipment. With 1,400 employees and 11 sites globally Nelipak is committed to delivering superior quality, service, and customer experience through world-class cleanroom manufacturing.

Nelson Labs is a global leader in microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. We serve over 3,000 customers from 12 facilities in the United States, Mexico, Asia and Europe and offer a comprehensive array of over 900 laboratory tests along with the expertise of Regulatory Compliance Associates, a recognized leader in regulatory consulting for the life sciences industry. We support our customers from initial product development and sterilization validation, through regulatory approval and ongoing product testing for sterility, safety and quality assurance.  We are regarded as a best-in-class partner with a strong track record of collaborating with customers to solve complex issues. Safeguarding Global Health® – with every test completed. Learn more: nelsonlabs.com.

Our vision is to become the most patient-centric drug delivery device solutions company. We design and manufacture drug delivery device solutions that maximize treatment efficacy and partner with our customers in their device strategies, to ultimately bring high quality and safe treatment solutions to patients. At Nemera, we put patients first! To learn more visit www.nemera.net

OnDosis is an AstraZeneca spinout addressing individualized and connected treatments through its proprietary drug delivery technology for oral solid drugs. The technology enables precise and flexible dosing in the patient’s home environment through a connected handheld device with associated digital solution, also supporting adherence and remote patient monitoring. To learn more, visit https://www.ondosis.com/

With more than 70 years’ experience in medical devices, Owen Mumford Pharmaceutical Services is a division of Owen Mumford, with the Head Office located in Woodstock, UK. Our global presence spans from manufacturing facilities in the UK and Malaysia to subsidiaries in the US, Germany and France. Owen Mumford Pharmaceutical Services specializes in the design, development and manufacture of injectable drug delivery systems for the pharmaceutical, biotech and generics industries. Our trusted devices are used daily in the delivery of various medications for a multitude of conditions across the globe. Our product portfolio includes single and multi-dose reusable and disposable auto-injectors, pens, and syringes for subcutaneous and intramuscular administration. Our flagship products include UniSafe® platform, a spring-free, passive safety device for 1ml and 2.25ml pre-filled syringes. UniSafe 1mL has regulatory approval as a combination product in Asia and Europe where it is also in patient use. Our most recent innovation is the 2-step disposable auto-injector Aidaptus®. Aidaptus can be used for both 1mL and 2.25mL syringes in the same base device. It can also readily adapt to different fill volumes using auto-adjust plunger technology providing a solution for formulation changes during development and lifecycle management. We are proud to have been awarded a distinction in the prestigious Red Dot awards for innovative product design 2023 for Aidaptus. For more information, visit https://www.ompharmaservices.com/

Paragon Medical serves as your strategic partner in medical device manufacturing, offering an end-to-end supply chain solution from product development, to verification and validation testing, to final production, assembly, and ongoing strategic demand planning. Discover how you can experience a consistently remarkable partnership through Paragon Medical’s differentiated and personalized solutions. To learn more, please visit www.paragonmedical.com

At PHC, we have enhanced our technological and manufacturing capabilities and extended our reach to contract development and manufacturing. We have earned a high level of trust from our corporate customers and built up an extensive track record in medical devices (not only drug delivery devices, but also in vitro diagnostic devices and sensors, etc.), for which we now undertake contract development and manufacturing. For more information, please visit https://www.phchd.com/global/ivd

Phosphorex is a leading provider of drug delivery technologies and solutions. By harnessing the potential of microspheres and nanoparticles for drug delivery, Phosphorex offers tailored solutions and enabling technologies to optimize a drug's release rate, targeting ability, bioavailability, and deliverability, with the goal of achieving desired therapeutic effects while reducing adverse clinical outcomes. Phosphorex supports pharmaceutical and biotech companies through all phases of their development, from proof of concept to clinical studies and will be offering cGMP manufacturing services soon. Phosphorex's mission is to help our partners solve complex problems and develop successful drugs to help patients. Additional information about Phosphorex is available at www.phosphorex.com or follow us on LinkedIn.

Pyramid Labs provides contract development, manufacturing and analytical services for parenteral drugs. From pre-clinical development to commercial supply and regulatory support, our expertise has enabled multiple clients to develop and launch their biologics, peptide and small molecule drugs. For more information, go to https://www.pyramidlabs.com/

Ritedose is the largest sterile CDMO in the U.S., specializing in Blow-Fill-Seal (BFS) technology for consistent, safe unit-dose delivery. From clinical trials to commercialization, Ritedose produces branded and generic inhalation and ophthalmic drugs, delivering high-quality, reliable medications that improve patient outcomes. Ritedose: Passion and Precision with a Purpose.

Rommelag Engineering’s BLOW-FILL-SEAL ADVANCED ASEPTIC LIQUID PACKAGING is the world leader in the manufacture of the filling machines. Achieve unparalleled flexibility, heightened performance, and uncompromising safety—all housed in the industry's most compact design. Packaging solutions with its bottelpack® Blow/Fill/Seal technology in plastic containers in a wide range of sizes and shapes that are formed, filled, and sealed within a single step, avoiding the need for pre-formed containers. We offer are machine construction and sales as well as CDMO services. For more information, visit https://www.rommelag.com

At RPK Medical, we stand out as your long-term partner, experts in crafting tailor-made solutions in the medical device sector. Our commitment goes beyond providing solutions – we aim to transform lives for the better. We prioritize listening to you, understanding your unique needs, and tailoring solutions that go beyond springs, stamping & bending or assemblies with precision and reliability. • 50 years of expertise in creating precision customized parts for security applications • Glocal service: thinking globally, acting locally. Factories in Europe, North America and Asia • Engineering excellence, tailor made for your needs • Customized cleaning and packaging (Clean rooms in Europe, North America and Asia) • A sustainable project, your long-term partner from design to manufacturing. For more information, visit https://rpk-medical.com/en or https://rpk-global.com/medical

RYCHIGER, AG - an innovative high-end technology solution provider at the forefront of LifeScience, IVDx, Drug delivery and Pharma Manufacturing. Developing manufacturing equipment, based on highly modular and scalable systems starting with concept studies, to semi-automatic lab-scale, through to fully automated high volume production lines. For more information, please visit https://www.rychiger.com/

Scherdel Medtech is a family owned, leading global, metal component solutions provider for the medical device and drug delivery markets. We don’t just provide solutions, we provide care. To learn more, visit https://www.scherdel.com/?lang=en

SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world – because human health matters. The portfolio comprises drug containment and delivery solutions for injectable drugs ranging from prefillable glass and polymer syringes, to cartridges, vials, and ampoules. To learn more, please visit www.schott-pharma.com

High quality single-use medical devices. Development, production, and registration – everything from one source for the global medical technology and pharmaceutical industry. Since the foundation of sfm medical devices GmbH in 1953, we, as a company, feel a responsibility to our employees, customers, suppliers, the environment, and society. Our precision single-use medical devices are used in many areas of human medicine and by the pharmaceutical industry. Numerous controlled manufacturing techniques and close collaboration amongst the different departments and subsidiaries results in outstanding quality. Mastering these collaborative efforts makes sfm unique in the market!

Shaily is a leading manufacturer specializing in the design and manufacturing of high-quality pens and autoinjectors for the pharmaceutical and medical device sectors. Our state-of-the-art manufacturing facilities are equipped with cutting-edge technology and automation, ensuring the highest standards of quality, reliability, and safety in every product we produce. We adhere to the ISO 15378 and 13485 Medical Device Single Audit Program (MDSP) Quality Management System (QMS) which demonstrates our dedication to maintaining rigorous quality control throughout our entire process and supports its customers with DMF, NDA, ANDA, and 510k filings from design and development to production and post-market activities. For more information, visit https://www.shaily.com/

Smithers supports medical device and pharmaceutical manufacturers with expert, independent testing across the product development cycle, from concept and materials to packaging and distribution. Our team provides guidance and data to meet FDA, EMA, MHRA, USP, ASTM, and ISO standards. With deep expertise and broad capabilities, Smithers helps bring innovative, high-performing products to market efficiently.

The unique application know-how and experience of the SOTAX Pharma Services team helps pharmaceutical companies worldwide in overcoming the various challenges associated with dissolution and release testing from pharmaceutical dosage forms. Specialized in in vitro dissolution testing, our team has a proven track record of finding the most suitable method for products ranging from APIs and tablets to implants, semi solids, and many more. Set in a US FDA-inspected facility, with a cGMP-compliant environment with strict quality management processes, the scientific expertise of our staff paired with state-of-the-art instrumentation ensures best in class services and ease of regulatory compliance for our customers. For more information, visit www.sotax.com

For more information please visit https://www.steripack.com/

TxSphere (“Tech Sphere”) was founded as a spin-off of Intuvie LLC to focus exclusively on the development and technology licensing of drug delivery devices for drug-device combination products. Our company’s foundation is built on our extensive experience with infusion pumps and combination drug delivery devices. Our flagship product is the Horizon III, a reusable wearable micro-pump. The disposable component includes a pre-fillable drug reservoir combined with a micro cannula insertion system. The Horizon III is capable of comfortably delivering high volume viscous biologicals, as well as small volumes. For more information, please visit www.tx2sphere.com.

For more information please visit https://ventura-solutions.com/

Weidmann Medical Technology AG is an independent swiss injection molding company serving the medical device and pharma industry. Its capabilities include automation, assembly and packaging; industrialisation and scale-up; quality control via in-line camera systems; high-volume plastic consumables. It has production sites with clean-room ISO Classes 7/8 in Switzerland and Mexico. To learn more, visit https://www.weidmann-medical.com/en/

Biograil has developed a proprietary oral delivery technology called BIONDD™ (pronounced BEYOND). The technology fits into a standard size (00 or 0) capsule effectively delivering the active substance to the systemic circulation. Biograil team members were R&D responsible for developing the world’s first FDA approved injection molded tablet. To learn more, please visit: https://biograil.com/

Daré’s mission is to challenge the status quo, making women’s health a priority. Our vision is to meet the increasing demand for evidence-based treatments with uncompromising scientific rigor and rapid, responsible commercialization. We aim to address decades of unmet needs by accelerating scientific innovation and bringing evidence-based treatment solutions from development to market.

For more information please visit https://www.extrupharm.com/

Imagine Pharma is a biotechnology company focused on the development of its IMG-1® polypeptide. Research and development efforts have led to the creation of three distinctive platforms for Oral Delivery, Therapeutics, and Regenerative Medicine. Each platform comprises first-in-class programs that address multiple disease states in large, underserved markets.

MUNIT is operating in the field of MICRONIZATION of Active Pharmaceutical Ingredients (APIs), High Potent APIs, Cytotoxic and Cytostatic compounds, Inhalation products, Steroids, R&D compounds and Generics. In MUNIT we have combined the technical and commercial expertise of its affiliates Jetpharma SA (Switzerland) and Microchem Srl (Italy). Our services: • Jet- , Pin- and Hammer milling • Cryogenic Micronization • Co- micronization • Sieving, Blending, De-Lumping • Technical trials, DoE Studies, Process development and validation • QbD • PSD analysis etc. To learn more, please visit https://www.munit.com/

Pendant Biosciences is an advanced materials biotech developing a proprietary biodegradable polymer technology utilizing cross-linked pendant functionalized polymers. This next-generation polymer system overcomes many of the limitations of older PLGA-based systems, is highly tunable and creates innovative long-acting injectable formulations for systemic and localized delivery. To learn more visit https://pendantbio.com/

For more information please visit https://promedpharmallc.com/

Rx Bandz is an award-winning female-founded, privately-held company with its laboratory in Denville, NJ. It is developing a versatile, next-generation platform of compact, patient-centric auto-injectors to deliver a wide range of injectable medications, from

Serina Therapeutics is a clinical-stage biotechnology company developing a pipeline of wholly owned drug product candidates to treat neurological diseases and other indications. Serina’s POZ Platform™ provides the potential to improve the integrated efficacy and safety profile of multiple modalities including small molecules, RNA-based therapeutics and antibody-based drug conjugates (ADCs). Serina is headquartered in Huntsville, Alabama on the campus of the HudsonAlpha Institute of Biotechnology.

For more information please visit https://www.vaxxas.com/

CarboHyde is a private preclinical pharmaceutical company specializing in cyclodextrin-based formulation and synthetic solutions. We actively seek partnerships across pharma, biotech, and related sectors to co-develop or support cyclodextrin-enabled applications, including advanced drug delivery, gene therapy, and vaccine technologies, as well as rare and neurodegenerative disease programs.

Hera Health Solutions, Inc. is a pharmaceutical device company specializing in the research, development, and commercialization of long-acting therapeutics through a proprietary nanotechnology-enabled bioerodible drug delivery platform. Our advanced nanofiber-based system enables precise control of drug release kinetics and enhanced bioavailability. We partner with pharmaceutical and biotech companies to accelerate reformulation programs with scalable, GMP-ready manufacturing for rapid clinical and commercial translation, and actively co-develop and license innovative long-acting drug delivery solutions.

Ossianix Inc has developed highly selective and potent brain shuttles. We use the single domain VNAR antibody platform targeting the transferrin receptor and the amino acid transporter CD98 to produce industry leading brain shuttles that deliver therapeutic levels of a broad range of drugs to the CNS including antibodies, enzymes, peptides and oligonucleotides (ASO& siRNA). Our lead oligo programs are MAPT and alpha synuclein for neurodegenerative disease which are in pre clinical development.

For more information please visit https://pituvia.com/

Sempresto is developing an innovative, cell-phone integrated point-of-care delivery system for rescue medications, such as epinephrine for anaphylaxis, midazolam for epileptic seizures, naloxone for opioid overdose, and others. We firmly believe that the most effective medication is the one that is there when you need it, one that is compatible with your active lifestyle and difficult to leave behind.

For more information please visit https://vgsktechnologies.com/